Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 2 of 25
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
NCT06959641
Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
NCT06995742
J-Tip Use for Paracentesis in Adults With Liver Cirrhosis and Ascites
NCT06996379
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
NCT06892704
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
NCT06466161
Mosaic Trial for Stem Cell Transplant Recipients
NCT06960993
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
NCT06944392
Micromanaging Human Sleep Physiology to Treat Sleep Apnea and Other Disorders
NCT06926036
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
NCT04664634
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
NCT07556380
Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)
NCT05942469
Electrophysiological Representations of Odor Identity Study 2
NCT07386236
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
NCT06813898
Response to Exercise and Nitric Oxide in PAD
NCT06657976
Community Intervention to Reduce CardiovascuLar Disease in Chicago
NCT04755153
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
NCT06630416
The SEQUENCE Trial: Evaluating Diagnostic Yield of Robotic-assisted Bronchoscopy When Staging EBUS is Performed First or Second in the Same Procedure
NCT06676956
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
NCT06517186
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
NCT06523569
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
NCT06630676
Shockwave in Postoperative Breast Reconstruction Fibrosis
NCT06919042
Noradrenergic Dysregulation, Sleep and Cognition in Older Adults with Insomnia
NCT06694441
Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT06242834
Fisetin to Reduce Senescence and Mobility Impairment in PAD
NCT06399809
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
NCT05687604
Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery
NCT06384079
XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma
NCT06571734
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
NCT06676930
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
NCT06499870
EAT: A Reliable Eating Assessment Technology for Free-living Individuals
NCT06118528
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
NCT06883175
Effect of Neural Constraints on Movement in Stroke
NCT06666673
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
NCT05042258
ENhancing Exercise with LIGHT to Improve Functioning in PAD
NCT06399900
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
NCT06293352
Segmentectomy After Induction Therapy (SAINT)
NCT06496659
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
NCT06617871
OTC Hearing Aid and MCI
NCT06112860
Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems
NCT06391073
Breast Cancer - Navigate - Prospective Cohort
NCT06271356
SMARTer Weight Loss Management
NCT05861973
Effectiveness and Implementation of Text Messaging to Improve HIV Testing in Adolescents
NCT06096519
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT05879250
MBC2OTP Project (Measurement-Based Care Implementation in Community Opioid Treatment Programs)
NCT06345274
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
NCT06327477
Electrophysiological Representations of Odor in the Human Brain Study 1
NCT06769464
Surgical Approach to Uterine Septum
NCT06315582
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
NCT06531473
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
NCT06245109
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
NCT06244004
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.